Mixed-Methods Study of End-of-Life Experiences of Patients With Hematologic Malignancies in Social Hospice Residential Home Care Settings

被引:0
|
作者
Weisse, Carol S. [1 ]
Melekis, Kelly [2 ]
Cheng, Alice [3 ]
Konda, Anuja Keerthi [3 ]
Major, Ajay [4 ]
机构
[1] Union Coll, Dept Psychol, Schenectady, NY USA
[2] Univ Vermont, Coll Educ & Social Serv, Burlington, VT USA
[3] Albany Med Coll, Albany, NY USA
[4] Univ Colorado, Sch Med, Dept Med, Div Hematol, Aurora, CO USA
关键词
MULTIPLE-MYELOMA; QUALITY; MANAGEMENT; CANCER; RISK;
D O I
10.1200/OP.23.00534
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSEHospice is underutilized by patients with hematologic malignancies (HM), and when patients are referred, they are typically more ill, hospitalized, and with shorter length of stay (LOS) than patients with solid tumors (ST), limiting research about home hospice care experiences of patients with HM. In this mixed-methods study, we examined the hospice experiences of patients with HM who died at residential care homes (RCHs), home-based settings in which volunteer caregivers and hospice staff provide end-of-life (EOL) care under the social hospice model.METHODSWe queried a registry of 535 hospice patients who died at RCHs between 2005 and 2020 that included quantitative medication administration data as well as qualitative data from hospice intake forms and written volunteer caregiver narratives. Qualitative data were analyzed by collective case study methodology. Quantitative comparisons of LOS and liquid morphine use were performed with matched patients with ST.RESULTSThe registry yielded 29 patients with HM, of whom qualitative data were available for 18 patients. Patients with HM exhibited common EOL symptoms (pain, dyspnea, and agitation). Instances of bleeding were low (22%), and notable HM-specific care concerns were described regarding bone fractures, skin integrity, and delirium. Most (78%) experienced good symptom management and peaceful or comfortable deaths. In only one case were symptoms described as severe and poorly managed. Patients with HM had comparable LOS on hospice and at the RCHs to patients with ST, with no group differences in liquid morphine use.CONCLUSIONIn this registry cohort, most patients with HM achieved good symptom management in home care settings with volunteer caregivers and hospice support. Caregivers may require additional counseling and palliative medications for HM-specific EOL symptoms. Patients with blood cancers in a home care hospice setting have unique end-of-life experiences.
引用
收藏
页码:779 / 786
页数:11
相关论文
共 50 条
  • [21] Hypodermoclysis as a Strategy for Patients With End-of-Life Cancer in Home Care Settings
    Coelho, Tatiana A.
    Wainstein, Alberto J. A.
    Drummond-Lage, Ana P.
    AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2020, 37 (09): : 675 - 682
  • [22] Palliative Care Effectively Guides Transition to Inpatient Hospice, Home Hospice or Home Services for End-of-Life Care of LVAD Patients
    Nakagawa, S.
    Blinderman, C.
    Cagliostro, B.
    Flannery, M.
    Topkara, V. K.
    Takeda, K.
    Takayama, H.
    Naka, Y.
    Colombo, P. C.
    Yuzefpolskaya, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S222 - S222
  • [23] Families' Perceptions of Inpatient and Home Hospice Care at End-of-Life
    De Sousa, Maysa
    Smith, Dawn
    Corcoran, Amy
    Bailey, F. Amos
    Furman, Christian
    Ritchie, Christine
    Rosenfeld, Kenneth
    Shreve, Scott
    Casarett, David
    ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (20) : 1856 - 1857
  • [24] '. . . and then no more kisses!' Exploring patients' experiences on multidrug-resistant bacterial microorganisms and hygiene measures in end-of-life care A mixed-methods study
    Heckel, Maria
    Sturm, Alexander
    Stiel, Stephanie
    Ostgathe, Christoph
    Herbst, Franziska A.
    Tiedtke, Johanna
    Adelhardt, Thomas
    Reichert, Karen
    Sieber, Cornel
    PALLIATIVE MEDICINE, 2020, 34 (02) : 219 - 230
  • [25] Effects of tertiary palliative care on the pattern of end-of-life care in patients with hematologic malignancies in Korea
    Kim, Dong Hyun
    Youk, Jeonghwan
    Byun, Ja Min
    Koh, Youngil
    Hong, Junshik
    Kim, Tae Min
    Kim, Inho
    Yoon, Sung-Soo
    Yoo, Shin Hye
    Shin, Dong-Yeop
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (05) : 743 - 755
  • [26] End-of-life care preferences of older patients with multimorbidity: protocol of a mixed-methods systematic review
    Isabel Gonzalez-Gonzalez, Ana
    Schmucker, Christine
    Nothacker, Julia
    Nguyen, Truc Sophia
    Brueckle, Maria-Sophie
    Blom, Jeanet
    van den Akker, Marjan
    Roettger, Kristian
    Wegwarth, Odette
    Hoffmann, Tammy
    Gerlach, Ferdinand M.
    Straus, Sharon E.
    Meerpohl, Joerg J.
    Muth, Christiane
    BMJ OPEN, 2020, 10 (07): : e038682
  • [27] Impact of Palliative Care Referrals on End-Of-Life Outcomes in Patients with Advanced Hematologic Malignancies
    Seecof, Olivia M.
    Jang, Charley Q.
    Kim, Arum
    Abdul-Hay, Maher
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2024, 67 (05) : E550 - E551
  • [28] Goal of a “Good Death” in End-of-Life Care for Patients with Hematologic Malignancies—Are We Close?
    Thomas M. Kuczmarski
    Oreofe O. Odejide
    Current Hematologic Malignancy Reports, 2021, 16 : 117 - 125
  • [29] Experiences of family caregivers of patients with terminal disease and the quality of end-of-life care received: a mixed methods study
    Marti-Garcia, Celia
    Fernandez-Alcantara, Manuel
    Suarez Lopez, Patricia
    Romero Ruiz, Carolina
    Munoz Martin, Rocio
    Paz Garcia-Caro, Ma
    PEERJ, 2020, 8
  • [30] End-of-life experiences in individuals with dementia with Lewy bodies and their caregivers: A mixed-methods analysis
    Wollney, Easton
    Sovich, Kaitlin
    Labarre, Brian
    Maixner, Susan M.
    Paulson, Henry L.
    Manning, Carol
    Fields, Julie A.
    Lunde, Angela
    Boeve, Bradley F.
    Galvin, James E.
    Taylor, Angela S.
    Li, Zhigang
    Fechtel, Hannah J.
    Armstrong, Melissa J.
    PLOS ONE, 2024, 19 (08):